Pseudohypoparathyroidism primary prevention

	Pseudohypoparathyroidism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pseudohypoparathyroidism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pseudohypoparathyroidism primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pseudohypoparathyroidism primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pseudohypoparathyroidism primary prevention
CDC on Pseudohypoparathyroidism primary prevention
Pseudohypoparathyroidism primary prevention in the news
Blogs on Pseudohypoparathyroidism primary prevention
Directions to Hospitals Treating Pseudohypoparathyroidism
Risk calculators and risk factors for Pseudohypoparathyroidism primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overview

Effective measures for the primary prevention of pseudohypoparathyroidism include genetic counseling in inherited cases.

Effective measures for the primary prevention of pseudohypoparathyroidism include genetic counseling in inherited cases.^[1]

↑ Mantovani G, Elli FM, Corbetta S (2017). "Hypothyroidism associated with parathyroid disorders". Best Pract. Res. Clin. Endocrinol. Metab. 31 (2): 161–173. doi:10.1016/j.beem.2017.04.004. PMID 28648505.